KCH Consumer Healthcare Limited (KCH), an indigenous healthcare company headquartered in Lagos, has announced that it has entered into agreement with the United States based Elysee Inc. for the marketing and distribution of nutraceuticals.
Under the terms of the agreement according to a statement issued by KCH, a copy of which was made available to journalists, Elysee Inc. granted KCH the exclusive right to market and distribute the dietary supplements to people living in sub-Saharan Africa.
“We are pleased to have KCH as our partner and our distribution agreement represents an important step to enable expanded market access to our products, KCH is a trusted and highly respected company with a broad customer base and deep knowledge of the needs of people and is ideally suited to market our brands,” said Wilson Moore, Director Business Development at Elysee Inc. USA.
“KCH is managing its operations to position the company for long term growth and success. We are pleased that we were able to come to an agreement with Elysee Inc United States to market, distribute and sell its advanced range of multivitamin products across sub-Sahara Africa,” stated Mr. Morgan Nwanguma, Head, Public Communications and New Media.
The dietary supplements covered under the agreement are to be unveiled to the Nigerian public in the coming weeks. Nutraceuticals or dietary supplements are fortified food products pharmaceutically formulated to assist in the treatment and prevention of disease.
The Elysee brand of nutraceuticals are emerging global brands recognised as advanced range of multivitamins, manufactured and packaged in the best traditions of pharmaceutical products formulation and under the license of Softech Pharma Pvt. Ltd. for all round nutritional support for both men and women including expectant mothers.
KCH is an emerging conglomerate with interests in pharmaceutical consulting, publishing, production and marketing of essential drugs across sub-Saharan Africa and considers its partnership with Elysee Inc. as strategic in its future plan to provide essential drugs at cost effective rates to peoples living across the African continent.
In keeping with the letters of its mission statement which emphasises offer of a unique range of products that combines quality with affordability and a culture of genuineness protected by technology, KCH says it is determined to ensure that the greatest majority of Africans have access to high quality generic medicines.